The volume of patient-initiated EHR messages “increased dramatically” after the onset of the COVID-19 pandemic and remained elevated through 2022, said A. Jay Holmgren, PhD.

While this pembrolizumab-based regimen is promising and much needed in this patient population, one should remain cognizant of its high costs and the subsequent impact this may have on patients and ...

(HealthDay News) — A measles outbreak in Texas has grown to 159 cases, and the US Centers for Disease Control and Prevention (CDC) has sent a team to help local health officials respond.

Recent cuts to the federal workforce could negatively impact cancer research and public health for years to come, researchers say.

The FDA has approved Stoboclo (denosumab-bmwo), a biosimilar to Prolia (denosumab), and Osenvelt (denosumab-bmwo), a biosimilar to Xgeva (denosumab).

Researchers sought to evaluate differences in ctDNA profiles, use of targeted treatments, and overall survival between Black and White patients with metastatic breast cancer.

As legal battles over the federal funding freeze and indirect cost payments from NIH play out in court, cancer research is being disrupted.

We think it can be appropriate to present phase 2 trial participation as offering a small prospect of benefit,” researchers wrote. About 16% of patients enrolled in phase 2 cancer trials receive a ...

Researchers evaluated links between lifestyle and dietary index scores and risk of death in a prospective, multiethnic cohort of men diagnosed with non-metastatic prostate cancer.